- Home
- XPL vs NVNO Comparison
XPL vs NVNO Comparison
Compare XPL & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPL
- NVNO
- Stock Information
- Founded
- XPL 1984
- NVNO 1987
- Country
- XPL United States
- NVNO United States
- Employees
- XPL N/A
- NVNO N/A
- Industry
- XPL Precious Metals
- NVNO Medical/Dental Instruments
- Sector
- XPL Basic Materials
- NVNO Health Care
- Exchange
- XPL Nasdaq
- NVNO Nasdaq
- Market Cap
- XPL 53.8M
- NVNO 62.4M
- IPO Year
- XPL N/A
- NVNO N/A
- Fundamental
- Price
- XPL $0.68
- NVNO $3.77
- Analyst Decision
- XPL Strong Buy
- NVNO
- Analyst Count
- XPL 2
- NVNO 0
- Target Price
- XPL $1.60
- NVNO N/A
- AVG Volume (30 Days)
- XPL 64.1K
- NVNO 99.9K
- Earning Date
- XPL 03-21-2025
- NVNO 03-03-2025
- Dividend Yield
- XPL N/A
- NVNO N/A
- EPS Growth
- XPL N/A
- NVNO N/A
- EPS
- XPL N/A
- NVNO N/A
- Revenue
- XPL N/A
- NVNO N/A
- Revenue This Year
- XPL N/A
- NVNO N/A
- Revenue Next Year
- XPL N/A
- NVNO N/A
- P/E Ratio
- XPL N/A
- NVNO N/A
- Revenue Growth
- XPL N/A
- NVNO N/A
- 52 Week Low
- XPL $0.43
- NVNO $2.45
- 52 Week High
- XPL $0.98
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- XPL 48.48
- NVNO 67.71
- Support Level
- XPL $0.68
- NVNO $3.48
- Resistance Level
- XPL $0.75
- NVNO $3.80
- Average True Range (ATR)
- XPL 0.05
- NVNO 0.26
- MACD
- XPL -0.00
- NVNO 0.06
- Stochastic Oscillator
- XPL 56.09
- NVNO 90.80
About XPL Solitario Resources Corp.
Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).